477 - Availability of Donor Derived Patient Specific Virus-Specific T-Cells (VSTs) Is Not Associated with Differences in Outcomes As Compared to Frontline Administration of Third Party Vsts for the Management of Viral Infections after Pediatric Hematopoietic Stem Cell Transplant

Autor: Galletta, Thomas J., Lane, Adam, Lutzko, Carolyn M., Leemhuis, Thomas, Cancelas, Jose A., Khoury, Ruby, Wang, YunZu M., Hanley, Patrick J., Keller, Michael D., Bollard, Catherine M., Davies, Stella M., Grimley, Michael S., Rubinstein, Jeremy D.
Zdroj: In Transplantation and Cellular Therapy March 2022 28(3) Supplement:S374-S375
Databáze: ScienceDirect